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Radiation-induced heart toxicity is one of the serious side effects after a radiation disaster or radiotherapy for 
patients with chest cancers, leading to a reduction in the quality of life of the patients. Evidence has shown that 
infiltration of inflammatory cells plays a key role in the development of functional damages to the heart via chronic 
upregulation of some pro-fibrotic and pro-inflammatory cytokines. These changes are associated with continuous 
free radical production and increased stiffness of heart muscle. IL-4 and IL-13 are two important pro-fibrotic 
cytokines which contribute to the side effects of ionizing radiation exposure. Recent studies have proposed that IL-4 
through upregulation of DUOX2, and IL-13 via stimulation of DUOX1 gene expression, are involved in the 
development of radiation late effects. In the present study, we aimed to detect changes in the expression of these 
pathways following irradiation of rat’s heart. Furthermore, we evaluated the possible protective effect of metformin 
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on the development of these abnormal changes. 20 male rats were divided into 4 groups (control, radiation, 
metformin treated, metformin + radiation). These rats were irradiated with 15 Gy 60Co gamma rays, and sacrificed 
after 10 weeks for evaluation of the changes in the expression of IL4R1, IL-13R2a, DUOX1 and DUOX2. In 
addition, the levels of IL-4 and IL-13 cytokines, as well as infiltration of macrophages and lymphocytes were 
detected. Results showed an upregulation of both DUOX1 and DUOX2 pathways in the presence of metformin, 
while the level of IL-13 did not show any significant change. This was associated with infiltration of macrophages 
and lymphocytes. Also, treatment with metformin could significantly attenuate accumulation of inflammatory cells, 
and upregulate these pathways. Therefore, suppression of dual oxidase genes by metformin may be a contributory 
factor to its protective effect. 
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adiotherapy is a non‐invasive cancer 
treatment modality prescribed for more than 
half of patients with solid tumors during their 
treatment course. However, acute and late 
detrimental effects of exposure to radiation affect 
the deliverable intensity of radiotherapy (1). In 
addition, these side effects can reduce the quality of 
life of cancer patients. Radiation-induced heart 
damage is one of the serious side effects after 
radiotherapy of lung and breast cancers (2, 3). 
Several studies have shown that in addition to the 
beneficial effect of radiotherapy in reducing local 
recurrences, there is some evidence showing that 
overall survival is hampered by an increased risk of 
non-cancerous diseases such as heart disease (4). 
Radiation-induced late cardiac damages such as 
coronary and carotid arteries diseases, ischemic 
heart disease etc., have been known for some 
decades (5). Earlier studies showed a high risk of 
heart diseases for women with left sided breast 
cancer who underwent radiotherapy (6). An 
increased risk of myocardial infarction (MI) for left 
breast cancer has been observed in comparison with 
the right side (7, 8). 
So far, several experiments have been 
conducted to detect the mechanisms involved in 
radiation-induced heart diseases. Amongst the 
various factors, fibrosis and inflammation play a 
key role (9). The long term upregulation of some 
cytokines such as interleukin 1 (IL-1), IL-4, IL-13, 
tumor necrosis factor alpha (TNF-α) and 
transforming growth factor beta (TGF-β) have 
pivotal roles in the development of radiation-
induced fibrosis (10). IL-4 and IL-13 are two 
important factors that through stimulation of 
reactive oxygen species (ROS) production promote 
the production of collagen and extracellular matrix, 
resulting in stiffness of normal tissue (11, 12). This 
effect causes damage to the normal function of 
tissues, especially in the lung, heart, and 
gastrointestinal organs (13). 
Although, advancements in radiotherapy 
techniques can improve the management of side 
effects, several studies have proposed some 
radioprotective agents for ameliorating long-term 
consequences. IL-4 is a key cytokine involved in 
the late effects of radiation especially fibrosis, and 
is mainly released by macrophages (14). In addition 
to its direct role in the late effects of radiation, it 
can stimulate the regulation of other pro-fibrotic 
and pro-inflammatory cytokines such as TGF-β and 
IL-13 (15). These cytokines stimulate the 
production of free radicals for a long period which 
mediates chronic oxidative injury and collagen 
deposition in intracellular space (16). Moreover, 
increased level of these cytokines can promote 
reduction/oxidation interaction, and stimulate 
carcinogenesis (17). Targeting IL-4 and IL-13 is an 
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interesting idea for suppressing the development of 
fibrosis after radiotherapy (18). However, 
amelioration of oxidative damage by some agents 
such as natural antioxidants, herbal compounds, and 
anti-inflammatory agents have shown promising 
results (19, 20). 
Metformin is an anti-diabetic drug which has 
shown some antioxidant, anti-fibrotic, and 
radioprotective effects (21, 22). Studies proposed 
that these effects of metformin are a result of 
suppression of some ROS mediator genes such as 
ubiquinone oxidoreductase, NADPH oxidase 4 
(NOX4), and stimulation of antioxidant enzymes 
(23-25). In this study, we evaluated the protective 
effect of metformin on radiation-induced heart 
injury, and regulation of IL-4 and IL-13 signaling 
pathways. 
 
Materials and methods 
Experimental design 
20 male rats were randomly divided into 4 
groups. Group 1: 5 rats were selected as controls 
without any intervention except intraperitoneal 
injection of ketamine and xylazine similar to other 
groups. Group 2: 5 rats received 100 mg/kg dose of 
metformin for 4 and 5 days before and after 
exposure to 15 Gy γ-rays, respectively. Metformin 
was administered 30 min before irradiation. Group 
3: 5 rats were treated with metformin for 10 days. 
Group 4: 5 rats received 15 Gy γ-rays to the heart 
without metformin treatment. At 10 weeks after 
irradiation, all rats were sacrificed and their heart 
tissues were extracted from the chest. Afterwards, 
both ventricles were fixed in 10% buffered formalin 
and auricles were frozen at -80 oC. 
Administration of metformin 
Metformin was purchased from Tehran Chemi 
Company, Tehran, Iran. It was dissolved in distilled 
water (20mg/ml) and administered to rats (1ml per 
day) orally for 9 consecutive days (4 and 5 days 
before and after irradiation respectively). On the 
day of irradiation, metformin was administered 30 
min before commencement. 100 mg/kg of 
metformin was selected as a non-toxic dose based 
on a previous study (26). 
Irradiation of animals 
Before irradiation, all rats were anesthetized 
with an intraperitoneal injection of ketamine and 
xylazine at doses of 80 and 5 mg/kg, respectively. 
In two groups, rats were irradiated locally on the 
chest area with a single dose of 15 Gy γ-rays and a 
radiation field of 6×6 cm2. This dose of radiation 
was selected according to previous studies for 
inducing heart injury (27). The source-to-skin 
distance was 60 cm with a dose rate of 109 
cGy/min. 
Gene expression analysis 
Total RNA was isolated from homogenates of 
auricles using TRIzol reagent (Sina gene, Iran). 
Afterwards, cDNA was synthetized using the 
reverse transcription kit (Takara, Japan). PCR 
reactions were performed in a volume of 10 
containing 5 l SYBR Green master mix (Takara, 
Japan). The expression of each gene was detected 
using real-time PCR with PGM1 as internal control. 
Primers for each gene are shown in table 1. Real-
Time PCR efficiency for all genes was determined 
using the slope of a linear regression which 
described by Pfaffl (28). 5 samples in each group 
were run in duplicate. 
 
Table 1. The sequence of primers for Real-time PCR. 
Gene  Forward sequence  Reverse sequence 
IL-4R1 GAGTGAGTGGAGTCCCAGCATC GCTGAAGTAACAGGTCAGGC  
IL-13Ra2 TCGTGTTAGCGGATGGGGAT  GCCTGGAAGCCTGGATCTCTA  
DUOX1 AAGAAAGGAAGCATCAACACCC ACCAGGGCAGTCAGGAAGAT  
DUOX2 AGTCTCATTCCTCACCCGGA  GTAACACACACGATGTGGCG   
PGM1 CATGATTCTGGGCAAGCACG GCCAGTTGGGGTCTCATACAAA 
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Evaluation of IL-4 and IL-3 levels 
The levels of both IL-4 and IL-13 were 
detected using ELISA kits (Zellbio ELISA kits, 
Germany) based on the manufacturer's protocol.  
Histopathological evaluation 
After fixation, the heart tissues were 
embedded in paraffin. Sections of the ventricles 
were cut at 5 µm, and then stained with 
hematoxylin and eosin (H&E). The obtained 
sections were evaluated for infiltration of 
macrophages and lymphocytes. All 
histopathological studies were performed at the 
Imam Khomeini Hospital, Tehran University of 
Medical Sciences, Tehran, Iran. The blinded 
evaluation was performed using a light microscope. 
Statistical analysis  
Data were analyzed using SPSS software 
version 16 (IBM, Chicago, USA). Real-time PCR 
results were analyzed by T-Test. ELISA results 
were analyzed by ANOVA test (Tukey’s HSD post 
hoc). Histopathological results were analyzed using 
Mann–Whitney. A P value <0.05 was considered as 
statistically significant. 
Results 
Gene expression analysis 
Irradiation of rat’s chest caused the 
upregulation of IL-4Ra1 (8.80±0.97 fold) in 
comparison with the control group (P= 0.009). 
Treatment with metformin led to a significant 
reduction in IL-4Ra1 in comparison with radiation 
group (3.47±0.41 fold, P= 0.006). Results showed a 
significant upregulation of IL13Ra2 (6.76±0.39 
fold, P < 0.001) compared to control, while its 
expression was attenuated when rats were treated 
with metformin (2.75±0.85 fold, P < 0.001). The 
expression of DUOX1 showed an increase 
following irradiation (5.40±0.65 fold, P < 0.001), 
however, its expression droped when treatment was 
performed using metformin (1.94±0.20 fold, P< 
0.001). We also observed that the exposure to 
irradiation caused a significant increase in the 
expression of DUOX2 in comparison with the 
control (12.69±2.09 fold, P= 0.01). Treatment with 
metformin resulted in potent decrease in DUOX2 
expression (0.73±0.45 fold, P= 0.016) (Figure 1). 
Evaluation of IL-4 and IL-3 levels 
Fig. 1. The expression of IL4Ra1, IL13Ra2, DUOX1, and DUOX2 in different groups. Results show an increase in the expression of genes 
following exposure to radiation. Treatment with metformin alleviates upregulation of these genes (t-test, P < 0.05, a=significant compared to 
control; b: significant compared to radiation group; MET=metformin treatment; RAD= Radiation group; RAD+MET= radiation plus 
metformin treatment). 
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Treatment with metformin alone did not cause 
any significant change in the level of IL-4. 
However, exposure to irradiation led to a significant 
increase of IL-4 in comparison with the control 
group (640±53 vs 413±37) (P=0.002). With 
metformin treatment before irradiation, the level of 
IL-4 decreased potently (339±44, p<0.001). In 
addition, ELISA results showed no significant 
change in the level of IL-13 (244.15±1.37 vs 
203.56±43.39) (Figure 2). 
Macrophages and lymphocytes infiltration 
Histopathological evaluation showed that 
irradiation caused a mild increase in the infiltration 
of inflammatory cells, including macrophages and 
lymphocytes. This was more obvious for 
lymphocytes. However, treatment with metformin 
completely reversed the infiltration of inflammatory 
cells (Figure 3). 
 
Discussion 
Radiation- induced heart damage is one of the 
most threatening non- cancerous diseases following 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The levels of IL-4 and IL-13 in rat’s heart tissues following irradiation or treatment with metformin before irradiation. 
Irradiation caused a significant increase in IL-4, while treatment with metformin before irradiation decreased its level. Data also did not 
show any significant change in the level of IL-13 (t-test, P < 0.05, a=significant compared to control; b: significant compared to radiation 
group; MET= metformin treatment; RAD= Radiation group; RAD+MET= radiation plus metformin treatment). 
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exposure to irradiation. Heart injury and subsequent 
diseases have been detected following whole body 
or partial body exposure to irradiation during a 
radiation disaster or radiotherapy (29). Incidence of 
heart diseases is one of the most common reasons 
of increased mortality among people who were 
exposed to irradiation during Hiroshima and 
Nagasaki atomic bomb explosion (30). Similarly, 
elevated heart diseases have been confirmed among 
the survivors of the Chernobyl disaster (30). This 
issue is more pronounced in patients with left breast 
cancer or lung cancer, when the heart is located 
within the radiation field (32). Evidence has 
proposed that increased cardiovascular disease  
such as carotid and coronary artery fibrosis, 
pericarditis, ischemia and hypertrophy are mostly 
common after exposure to irradiation. Histological 
studies have shown that accumulation of 
inflammatory cells such as mast cells, 
macrophages, and lymphocytes play a key role in 
chronic oxidative damage, inflammation and 
fibrosis, leading to changes in the normal structure 
of heart tissue and increased risk of heart attack 
(33). 
It has been confirmed that accumulation of 
inflammatory cells following exposure to 
irradiation mediates normal tissue destruction 
through various signaling pathways. Increased 
levels of IL-1, IL-4, IL-6, IL-8, IL-13, IL-33, TGF-
β, and TNF-α have been observed in several studies 
(1). In this study, we aimed to evaluate whether or 
not IL-4–IL4Ra1 and IL-13–IL13Ra2 signaling 
pathways are increased following exposure of the 
heart to irradiation. A previous study by Hassani et 
al. showed that IL-4 through DUOX2 and IL-13 
through DUOX1 promote chronic ROS production 
in thyroid tumor cells (34). As shown in figure 3, 
exposure of rat’s heart to radiation led to significant 
infiltration of macrophages and lymphocytes. 
Figure 2 shows a significant increase in the level of 
IL-4, but not IL-13. We also evaluated the 
expression of downstream genes, including IL-
4Ra1, IL13Ra2, DUOX1, and DUOX2. Results 
indicated that exposure to radiation led to a 
Fig. 3. Infiltration of inflammatory cells (mainly lymphocytes) in the heart tissues following irradiation of rat’s chest. Infiltration of these 
cells in radiation + metformin group was similar to control group. A: Control; B: metformin; C: radiation; D: radiation + metformin (H&E 
staining). 
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significant upregulation of all examined genes. 
Hence, both DUOX1 and DUOX2 are potential 
pathways that are upregulated following irradiation 
of the heart, and may be involved in radiation 
toxicity. Treatment with metformin caused potent 
attenuation of these genes associated with 
amelioration of infiltration of macrophages and 
lymphocytes. Probably, upregulation of DUOX1 
and IL13Ra2 are mediated through other signaling 
pathways. It has been confirmed that in addition to 
IL-13, DUOX1 and IL13Ra2 can be upregulated 
through IL-4 (35). There is a possibility that IL-4 
upregulates DUOX1 and DUOX2 genes expression 
through stimulation of IL4Ra1, while IL-13 and IL-
13Ra2 has no effect on this pathway. Moreover, 
some other cytokines such as interferon gamma 
(IFN-γ) have shown stimulatory effects on the 
expression of these genes (34, 36). 
So far, some agents have been proposed for 
protection against heart injuries due to irradiation. 
In our previous study, we showed that hesperidin as 
a natural agent has the ability to alleviate 
infiltration of immune cells including macrophages, 
lymphocytes and mast cells. This was associated 
with alleviation of collagen accumulation, and 
decreased oxidative stress (37). Gurses et al. 
evaluated the radioprotective effect of amifostine in 
rat’s heart tissues. They showed that a 200 mg/kg 
dose was able to alleviate necrosis and vascular 
damage in heart cells, while it could not prevent 
fibrosis in epicardial and myocardial tissues (38). In 
another study, they showed that melatonin can 
attenuate late effects of irradiation such as fibrosis, 
vasculitis, and necrosis in rat’s heart (39). 
In recent years, some studies have been 
conducted to evaluate the radioprotective effects of 
metformin in both in vitro and in vivo studies. In an 
in vitro study, Cheki et al. showed that pre-
treatment with metformin can reduce the formation 
of micronuclei in human lymphocytes (40) while an 
in vivo study by Xu et al. showed that metformin 
via down-regulation of NADPH oxidase 4 (NOX4) 
reduces chronic ROS production in the 
hematopoietic stem cells of mice (22). Miller et al. 
showed that treatment of mice with metformin 
before or even 24 h after exposure to irradiation can 
mitigate lethal effects of radiation by a protection 
factor of 1.8 (26). In the present study, our results 
propose that metformin treatment can attenuate the 
upregulation of dual oxidase genes in rat’s heart 
following exposure to ionizing radiation. Although, 
the exact mechanisms for radioprotective effect of 
metformin remain to be elucidated, it seems that 
antioxidant and anti-inflammatory effects play an 
important role (41). Also, through stimulation of 5' 
adenosine monophosphate-activated protein kinase 
(AMPK), metformin is able to induce DNA repair, 
leading to the reduction of accumulated DNA 
damage and cell death (42, 43). Antioxidant 
property of metformin that is mediated through 
stimulation of antioxidant enzymes may reduce 
radiation injury via neutralization of radiation-
induced ROS and DNA damage, and also 
modulation of inflammatory cells activity (25). 
Also, via enhancement of DNA repair capacity 
(which is critical after exposure to ionizing 
radiation), metformin may attenuate long term 
consequences of radiation (26, 44). DNA damage 
and cell death following exposure to radiation cause 
the release of several pro-inflammatory and pro-
fibrotic cytokines, which mediate the upregulation 
of pro-oxidant enzymes (17). These changes are 
responsible for several side effects. Thus, 
metformin may through attenuation of free radical 
production, DNA damage response as well as 
cytokines release, mediate several side effects 
following exposure to radiation. 
Metformin has shown the ability to protect the 
heart against toxic effects of other agents such as 
chemotherapy drugs. A study by Zilinyi et al. 
revealed the protective effect of metformin against 
doxorubicin cytotoxicity in rats. Results showed 
that treatment of rats with metformin reduces 
oxidative injury and ameliorates increased level of 
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troponin (a marker of cardiac toxicity). Moreover, 
metformin treatment reduced the thickening of 
myofibrillum in heart muscles (45). Moreover, it 
has been shown that metformin alleviates 
inflammation, apoptosis induction, and histological 
changes in rat’s heart tissues following doxorubicin 
injection (46, 47). 
In conclusion, the present study showed that 
exposing rat’s chest to irradiation caused a 
significant upregulation of proinflammation and 
pro-fibrotic genes including IL4Ra1, IL-13Ra2, 
DUOX1, and DUOX2 in heart tissues. Moreover, 
infiltration of macrophages and lymphocytes 
increased. Treatment with metformin led to potent 
inhibitory effects on both histopathological changes 
and all mentioned genes. Our results showed that 
IL-13 is not involved in heart injury following 
exposure to irradiation. 
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